共 387 条
[1]
Bray F(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 68 394-424
[2]
Ferlay J(2018)Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries Lancet 391 1023-1075
[3]
Soerjomataram I(2018)Modified XELIRI (capecitabine plus irinotecan) versus FOLFIRI (leucovorin, fluorouracil, and irinotecan), both either with or without bevacizumab, as second-line therapy for metastatic colorectal cancer (AXEPT): a multicentre, open-label, randomised, non-inferiority, phase 3 trial Lancet Oncol 19 660-671
[4]
Siegel RL(2008)NLR proteins: integral members of innate immunity and mediators of inflammatory diseases J Leukoc Biol 83 13-30
[5]
Torre LA(2010)Immunity, inflammation, and cancer Cell 140 883-899
[6]
Jemal A(2019)NOD-like receptor signaling in inflammation-associated cancers: from functions to targeted therapies Phytomedicine 64 152925-18389
[7]
Allemani C(2012)Tissue-specific opposing functions of the inflammasome adaptor ASC in the regulation of epithelial skin carcinogenesis Proc Natl Acad Sci U S A 109 18384-9867
[8]
Matsuda T(2013)Microbiota-induced activation of epithelial IL-6 signaling links inflammasome-driven inflammation with transmissible cancer Proc Natl Acad Sci U S A 110 9862-1199
[9]
Di Carlo V(2010)Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome Gut 59 1192-624
[10]
Harewood R(2014)NOD-like receptors: master regulators of inflammation and Cancer Front Immunol 5 327-737